Sign in
Companies / BDX vs PODD

BDX vs PODD: Becton Dickinson and Insulet

Medical Devices
Compare more companies

Becton Dickinson (BDX) reported $21.8B in revenue against a 7.7% net margin, while Insulet (PODD) reported $2.7B at a 9.1% net margin, most recently.

MetricBDXPODD
Revenue$21.8B$2.7B
Net Income$1.7B$0.2B
Gross Margin45.4%71.6%
Operating Margin11.8%17.5%
EPS (Diluted)$5.82$3.48
Free Cash Flow$2.7B$0.4B
Total Debt$19.2B$0.9B
P/E Ratio32.2×81.7×
P/B Ration/m13.2×
Stock Price$211.95$153.92
Free: last 5 years
Fiscal yearFY2009 🔒FY2010 🔒FY2011 🔒FY2012 🔒FY2013 🔒FY2014 🔒FY2015 🔒FY2016 🔒FY2017 🔒FY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
BDX Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$19.1B$18.9B$19.4B$20.2B$21.8B
PODD Revenue••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••$1.1B$1.3B$1.7B$2.1B$2.7B

More on BDX

More on PODD

Other comparisons